uniQure N.V.

NasdaqGS:QURE Stock Report

Market Cap: US$1.1b

uniQure Future Growth

Future criteria checks 2/6

uniQure is forecast to grow earnings and revenue by 35.8% and 50.1% per annum respectively while EPS is expected to grow by 39.5% per annum.

Key information

35.8%

Earnings growth rate

39.53%

EPS growth rate

Biotechs earnings growth23.3%
Revenue growth rate50.1%
Future return on equityn/a
Analyst coverage

Good

Last updated17 Apr 2026

Recent future growth updates

uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 03
uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Recent updates

A Unique Situation For UniQure

Mar 12
User avatar

AMT-130 Approval Will Transform Huntington's Treatment Pipeline

Accelerated approval of AMT-130 for Huntington's could significantly boost future revenues as it would be a pioneering treatment.

Is uniQure (NASDAQ:QURE) A Risky Investment?

May 10
Is uniQure (NASDAQ:QURE) A Risky Investment?

uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting

Apr 19

uniQure: Gene Therapy Specialist Looks Set For Upside As Huntington's Approval Beckons

Feb 20

uniQure's AMT-130: A Bold Step For Huntington's, But Not Without Hurdles

Dec 10

Is There An Opportunity With uniQure N.V.'s (NASDAQ:QURE) 39% Undervaluation?

Dec 07
Is There An Opportunity With uniQure N.V.'s (NASDAQ:QURE) 39% Undervaluation?

uniQure's Yellow Flags: Early-Stage Gene Therapies Amid Restructuring

Oct 21

uniQure: Pullback After Strong Interim Treatment Data Creates Buying Opportunity

Aug 06

uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 03
uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know

uniQure: Positive HD AMT-130 Treatment Data Leads To Several Other Catalysts

Jul 09

Earnings Update: uniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Are Trimming Their Forecasts

Mar 03
Earnings Update: uniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Are Trimming Their Forecasts

uniQure: The Valuation Got More Attractive

Feb 01

Little Excitement Around uniQure N.V.'s (NASDAQ:QURE) Revenues As Shares Take 29% Pounding

Jan 17
Little Excitement Around uniQure N.V.'s (NASDAQ:QURE) Revenues As Shares Take 29% Pounding

A Look At The Fair Value Of uniQure N.V. (NASDAQ:QURE)

Dec 15
A Look At The Fair Value Of uniQure N.V. (NASDAQ:QURE)

Revenue Downgrade: Here's What Analysts Forecast For uniQure N.V. (NASDAQ:QURE)

Aug 27
Revenue Downgrade: Here's What Analysts Forecast For uniQure N.V. (NASDAQ:QURE)

Earnings and Revenue Growth Forecasts

NasdaqGS:QURE - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028151-166-208-1868
12/31/2027106-188-219-14611
12/31/202634-205-51-17112
12/31/202516-199-178-178N/A
9/30/202516-235-154-153N/A
6/30/202514-199-174-173N/A
3/31/202520-218-167-166N/A
12/31/202427-240-186-183N/A
9/30/202429-240-185-179N/A
6/30/202428-285-111-104N/A
3/31/202419-297-135-128N/A
12/31/202316-308-153-146N/A
9/30/2023112-228-161-151N/A
6/30/2023112-187-251-239N/A
3/31/2023110-157-214-198N/A
12/31/2022106-127-163-145N/A
9/30/202261-125-154-137N/A
6/30/202262-114-149-129N/A
3/31/2022525324286304N/A
12/31/2021524330271288N/A
9/30/2021500321281298N/A
6/30/2021500303292303N/A
3/31/202138-139-154-143N/A
12/31/202038-125-144-135N/A
9/30/20206-166-132-124N/A
6/30/20205-136-120-111N/A
3/31/20206-124-114-105N/A
12/31/20197-124-105-99N/A
9/30/20196-105N/A-91N/A
6/30/20198-103N/A-89N/A
3/31/20199-92N/A-81N/A
12/31/201811-83N/A-76N/A
9/30/201812-90N/A-76N/A
6/30/201811-78N/A-71N/A
3/31/201813-78N/A-74N/A
12/31/201713-79N/A-64N/A
9/30/201720-67N/A-62N/A
6/30/201725-72N/A-65N/A
3/31/201724-71N/A-68N/A
12/31/201625-73N/A-72N/A
9/30/201620-76N/A-81N/A
6/30/201616-90N/A-62N/A
3/31/201614-90N/A5N/A
12/31/201511-82N/A7N/A
9/30/20158-76N/A22N/A
6/30/20156-58N/A13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: QURE is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: QURE is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: QURE is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: QURE's revenue (50.1% per year) is forecast to grow faster than the US market (10.9% per year).

High Growth Revenue: QURE's revenue (50.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if QURE's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/20 05:27
End of Day Share Price 2026/04/20 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

uniQure N.V. is covered by 33 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Eliana MerleBarclays
Vincent ChenBernstein